Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants

Abstract

A monocomponent pertussis toxoid vaccine induces significant protection against pertussis for at least 2 years after the third injection. To obtain an unbiased estimate of vaccine efficacy it is important to determine antibodies against an antigen that is not included in the vaccine.